PKCι, PKCζ and Par6 are required for pancreatic cancer cell transformed growth; thus, we hypothesized that molecular inhibition of aPKC PB1-domain-mediated interactions will inhibit the transformed signaling of both PKCι and PKCζ. The gene discussed is PRKCI; the disease is familial pancreatic carcinoma.